The serous ovarian cancer dataset indicated that the percentages of DNA alterations of MCMs were 5% (MCM2), 4% (MCM3), 5% (MCM4), 2.6% (MCM5), 1.2% (MCM6), and 5% (MCM7) (Figures 5A, B). Here, MCM2 is linked to ovarian serous adenocarcinoma.